RESEARCH ALERT-S&P Capital IQ starts Onyx Pharma with buy rating

Oct 12 (Reuters) - Onyx Pharmaceuticals Inc :

* S&P Capital IQ starts Onyx pharma with buy rating; price target $105

For a summary of rating and price target changes on U.S. companies:

Reuters Eikon users, click on

Reuters 3000Xtra users, double-click

Reuters Station users, click .1568

For a summary of rating and price target changes on Canadian companies:

Reuters Eikon users, click on

Reuters 3000Xtra users, double-click

Reuters Station users, click .4899

((Bangalore Newsroom [phone]; within U.S. [phone]))